Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage

Clinical trial NCT02670824 · COMPLETED

Trial details

NCT number: NCT02670824
Sponsor: AegisCN LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Intracerebral Hemorrhage (ICH)

Start date: 2015-12-01
Primary completion: 2016-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.